Incidence, risk factors and clinical outcome of venous thromboembolism in non-small cell lung cancer patients receivingimmune checkpoint inhibition

Birgitte Bjørnhart*, Karin Holmskov Hansen, Trine Lembrecht Jørgensen, Jørn Herrstedt, Tine Schytte

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Article number100056
Number of pages8
JournalThrombosis Update
Volume4
DOIs
Publication statusPublished - 2021

Cite this